- Home
- JZXN vs IMNN Comparison
JZXN vs IMNN Comparison
Compare JZXN & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- IMNN
- Stock Information
- Founded
- JZXN 2019
- IMNN 1982
- Country
- JZXN China
- IMNN United States
- Employees
- JZXN N/A
- IMNN N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- IMNN Health Care
- Exchange
- JZXN Nasdaq
- IMNN Nasdaq
- Market Cap
- JZXN 10.3M
- IMNN 12.1M
- IPO Year
- JZXN 2021
- IMNN 1985
- Fundamental
- Price
- JZXN $1.16
- IMNN $0.60
- Analyst Decision
- JZXN
- IMNN Buy
- Analyst Count
- JZXN 0
- IMNN 2
- Target Price
- JZXN N/A
- IMNN $14.00
- AVG Volume (30 Days)
- JZXN 454.6K
- IMNN 1.3M
- Earning Date
- JZXN 09-08-2025
- IMNN 08-13-2025
- Dividend Yield
- JZXN N/A
- IMNN N/A
- EPS Growth
- JZXN N/A
- IMNN N/A
- EPS
- JZXN N/A
- IMNN N/A
- Revenue
- JZXN $1,400,139.00
- IMNN N/A
- Revenue This Year
- JZXN N/A
- IMNN N/A
- Revenue Next Year
- JZXN N/A
- IMNN N/A
- P/E Ratio
- JZXN N/A
- IMNN N/A
- Revenue Growth
- JZXN N/A
- IMNN N/A
- 52 Week Low
- JZXN $0.84
- IMNN $0.37
- 52 Week High
- JZXN $7.82
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- JZXN 35.46
- IMNN 35.40
- Support Level
- JZXN $0.94
- IMNN $0.70
- Resistance Level
- JZXN $1.06
- IMNN $0.86
- Average True Range (ATR)
- JZXN 0.09
- IMNN 0.07
- MACD
- JZXN 0.09
- IMNN -0.03
- Stochastic Oscillator
- JZXN 88.70
- IMNN 0.05
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).